Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Environmental Bio-Detection Products (EBPI) is a private Canadian environmental biotechnology company that develops, manufactures, and applies rapid bioassay systems for detecting toxicity, genotoxicity, and mutagenicity in environmental and chemical samples. The company markets testing kits and laboratory services used across drinking water, wastewater, soil, air, industrial effluents, foods, cosmetics, pharmaceuticals, and chemical safety evaluation. Its product portfolio includes toxicity assays using organisms such as bacteria, algae, rotifers, crustaceans, and higher plants, as well as genotoxicity and mutagenicity tools including SOS-ChromoTest, umuC assay offerings, and Ames-format kits. EBPI appears to operate as a commercial research-tools and testing-services business rather than a therapeutic drug developer. The company also highlights work with regulators, academic groups, and environmental organizations, including projects aligned with ISO, OECD, and US EPA-related standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Environmental Bio-Detection Products.